Ordeniza, Elisa C.
HRN: 17-13-72 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/01/2025
CEFTAZIDIME 1GM (VIAL)
01/01/2025
01/08/2025
IVTT
2g
Q8
DM FOOT
Waiting Final Action
Indication: Empiric Type of Infection: Bone & Joint Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes